lutetium Lu 177 DOTA-biotin
Term · Oncology and biomedicine · MLC-T-ONC-014911
A radioconjugate of biotin conjugated with the bifunctional, macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) and labeled with the beta-emitting isotope lutetium Lu 177 (Lu-177) that can be used for radioimmunotherapeutic purposes. Lutetium Lu 177 DOTA-biotin could be used in pre-targeting radioimmunotherapy, which pretreats the lesion with oxidized avidin that binds to protein amino groups on cells. As avidin binds to biotin, the radioisotope can be selectively delivered to cancer cells leading to tumor cell eradication.
| Identifier | MLC-T-ONC-014911 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | [177Lu]DOTA-biotin; 177Lu-ST2210 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014911",
"term": "lutetium Lu 177 DOTA-biotin",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate of biotin conjugated with the bifunctional, macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) and labeled with the beta-emitting isotope lutetium Lu 177 (Lu-177) that can be used for radioimmunotherapeutic purposes. Lutetium Lu 177 DOTA-biotin could be used in pre-targeting radioimmunotherapy, which pretreats the lesion with oxidized avidin that binds to protein amino groups on cells. As avidin binds to biotin, the radioisotope can be selectively delivered to cancer cells leading to tumor cell eradication.",
"synonyms": [
"[177Lu]DOTA-biotin",
"177Lu-ST2210"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lutetium-lu-177-dota-biotin/"
}
Record 10,394 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.